Literature DB >> 8875404

Quantification of citrate concentration in the prostate by proton magnetic resonance spectroscopy: zonal and age-related differences.

M Lowry1, G P Liney, L W Turnbull, D J Manton, S J Blackband, A Horsman.   

Abstract

A commercial phased-array multicoil was used to acquire water-suppressed localized proton spectra of the two major anatomical regions of the prostate. The signal-to-noise ratio and spectral resolution allowed identification of peaks from choline and creatine, as well as a major peak from citrate. Quantification of the citrate peak using experimentally determined relaxation parameters with tissue water as an internal concentration reference revealed a marked variability between different volunteers. Nevertheless, in each case, the citrate concentration was up to fourfold greater in the peripheral zone than in the central gland. Furthermore, the difference in citrate concentration between these two regions was positively correlated with the subjects age. The results indicate a consistent difference in cellular function between the major anatomical regions within the prostate and may have important consequences for the application of magnetic resonance spectroscopy to the diagnosis of prostatic pathology.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8875404     DOI: 10.1002/mrm.1910360305

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  10 in total

Review 1.  Prostate MR imaging at high-field strength: evolution or revolution?

Authors:  Olivier Rouvière; Robert P Hartman; Denis Lyonnet
Journal:  Eur Radiol       Date:  2005-09-10       Impact factor: 5.315

2.  Two-dimensional MR spectroscopy of healthy and cancerous prostates in vivo.

Authors:  M Albert Thomas; Thomas Lange; S Sendhil Velan; Rajakumar Nagarajan; Steve Raman; Ana Gomez; Daniel Margolis; Stephany Swart; Raymond R Raylman; Rolf F Schulte; Peter Boesiger
Journal:  MAGMA       Date:  2008-07-17       Impact factor: 2.310

Review 3.  Citrate in the diagnosis of prostate cancer.

Authors:  L C Costello; R B Franklin; P Narayan
Journal:  Prostate       Date:  1999-02-15       Impact factor: 4.104

4.  Absolute choline tissue concentration mapping for prostate cancer localization and characterization using 3D 1 H MRSI without water-signal suppression.

Authors:  Nassim Tayari; Alan J Wright; Arend Heerschap
Journal:  Magn Reson Med       Date:  2021-09-23       Impact factor: 3.737

5.  The aging effect on prostate metabolite concentrations measured by 1H MR spectroscopy.

Authors:  Monika Dezortova; Filip Jiru; Antonin Skoch; Vaclav Capek; Zuzana Ryznarova; Viktor Vik; Milan Hajek
Journal:  MAGMA       Date:  2016-08-13       Impact factor: 2.310

Review 6.  Role of magnetic resonance methods in the evaluation of prostate cancer: an Indian perspective.

Authors:  Naranamangalam R Jagannathan; Virendra Kumar; Rajeev Kumar; Sanjay Thulkar
Journal:  MAGMA       Date:  2008-07-17       Impact factor: 2.310

7.  Proton magnetic resonance spectroscopy with a body coil in the diagnosis of carcinoma prostate.

Authors:  Rajeev Kumar; Mahesh Kumar; N R Jagannathan; Narmada P Gupta; Ashok K Hemal
Journal:  Urol Res       Date:  2003-10-08

Review 8.  Developments in proton MR spectroscopic imaging of prostate cancer.

Authors:  Angeliki Stamatelatou; Tom W J Scheenen; Arend Heerschap
Journal:  MAGMA       Date:  2022-04-20       Impact factor: 2.533

9.  Evaluation of short-TE (1)H MRSI for quantification of metabolites in the prostate.

Authors:  Meer Basharat; Maysam Jafar; Nandita M deSouza; Geoffrey S Payne
Journal:  NMR Biomed       Date:  2014-02-12       Impact factor: 4.044

10.  TE = 32 ms vs TE = 100 ms echo-time (1)H-magnetic resonance spectroscopy in prostate cancer: Tumor metabolite depiction and absolute concentrations in tumors and adjacent tissues.

Authors:  Meer Basharat; Geoffrey S Payne; Veronica A Morgan; Chris Parker; David Dearnaley; Nandita M deSouza
Journal:  J Magn Reson Imaging       Date:  2015-08-10       Impact factor: 4.813

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.